Skip to main content
. 2022 Nov 19;14(11):2514. doi: 10.3390/pharmaceutics14112514

Table 1.

Mutant forms and post-translational modifications of Pink1 and Parkin and their pathological mechanisms.

Protein Mutation or Modification Pathological Mechanism
Pink1 I368N Impossibility of binding to the outer mitochondrial membrane
Pink1 p.Q456X Decreasing of mRNA level
Pink1 p.G411S Partial loss of kinase activity
Parkin UBL domain (1) Decrease in Parkin phosphorylation
Parkin UBL domain (2) Parkin degradation
Pink1 S-nitrosylation Loss of kinase activity
Pink1 G309D Accumulation of α-synuclein